Steroid receptor antagonist mifepristone inhibits the anti-inflammatory effects of photoradiation

Photomedicine and Laser Surgery

Volumn 24, Issue 2, 2006, Pages 197-201

  Lopes Martins, Rodrigo Alvaro Brandão ^a   Albertini, Regiane ^a   Lopes Martins, Patrícia Sardinha Leonardo ^a   De Carvalho, Flávio Aimbire Soares ^a   Farianeto, Hugo Caire Castro ^b   Iversen, Vegard Vereide ^c   Bjordal, Jan Magnus ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b IOC   (Brazil)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; DRUG PRODUCTS; PATIENT TREATMENT; RADIATION;

ANTI-INFLAMMATORY EFFECT; INTRATHORACIC INJECTIONS; PHARMACOLOGICAL AGENTS; PHOTORADIATION;

DRUG THERAPY;

ALUMINUM; ARSENIC; CARRAGEENAN; GALLIUM ALUMINUM ARSENIDE; GALLIUM ARSENIDE; MIFEPRISTONE; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIODE LASER; IRRADIATION; LEUKOCYTE COUNT; MALE; MOUSE; NONHUMAN; PHOTOTHERAPY; PLEURISY; STEROID THERAPY; TREATMENT OUTCOME;

EID: 33744807981     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2006.24.197     Document Type: Article

References (35)

1. Gam, A.N., Thorsen, H., and Lonnberg, F. (1993). The effect of low-level laser therapy on musculoskeletal pain, a meta-analysis. Pain 52, 63-66.
2. Bjordal, J., Couppé, C., and Ljunggreen, A. (2001). Low-level laser therapy for tendinopathy. Evidence of a dose-response pattern. Phys. Ther. Rev. 6, 91-99.
3. Bjordal, J.M., Couppe, C., Chow, R.T., et al. (2003). A systematic review of low-level laser therapy with location-specific doses for pain from chronic joint disorders. Aust. J. Physiother. 49, 107-116.
4. Li, L.C. (2005). What else can I do but take drugs? The future of research in nonpharmacological treatment in early inflammatory arthritis. J. Rheumatol. Suppl. 72, 21-24.
5. Ottawa, Panel. (2004). Ottawa Panel Evidence-Based Clinical Practice Guidelines for Electrotherapy and Thermotherapy Interventions in the Management of Rheumatoid Arthritis in Adults. Phys. Ther. 84, 1016-1043.
6. Brosseau, L., Welch, V., Wells, G., et al. (2000). Low-level laser therapy (classes I, II and III) in the treatment of rheumatoid arthritis. Cochrane Database Syst. Rev. 2.
7. Brosseau, L., Welch, V., Wells, G., et al. (2004). Low-level laser therapy (Classes I, II and III) for treating osteoarthritis. Cochrane Database Syst. Rev. CD002046.
8. Norwegian Research Centre for Health Services, Nilsen, E.M., Bjordal, J.M., et al. (2004). Effect of physiotherapy for knee osteoarthritis, limited to electrotherapy and exercise therapy (Norwegian). Health Technol. Assessment Rep. 1-104.
9. FDA. (2004). Pre-market approval for lasers [On-line]. Available: www.fda.gov/cdrh/consumer/laserfacts.html#7.
10. Philadelphia, Panel. (2001). Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for shoulder pain. Phys. Ther. 81, 1719-1730.
11. Slordal, L., and Rygnestad, T. (2003). [Are local steroid injections effective or not?] Tidsskr. Nor. Laegeforen. 123, 3224-3225.
12. Zink, A., Listing, J., Niewerth, M., et al. (2001). The national database of the German Collaborative Arthritis Centres. II. Treatment of patients with rheumatoid arthritis. Ann. Rheum. Dis. 60, 207-213.
13. Hall, J., Clarke, A.K., Elvins, D.M., et al. (1994). Low-level laser therapy is ineffective in the management of rheumatoid arthritic finger joints. Br. J. Rheumatol. 33, 142-147.
14. Heussler, J.K., Hinchey, G., Margiotta, E., et al. (1993). A double blind randomised trial of low power laser treatment in rheumatoid arthritis. Ann. Rheum. Dis. 52, 703-706.
15. Albertini, R., Aimbire, F.S., Correa, F.I., et al. (2004). Effects of different protocol doses of low power gallium-aluminum-arsenate (Ga-Al-As) laser radiation (650 nm) on carrageenan-induced rat paw ooedema. J. Photochem. Photobiol. B 74, 101-107.
16. Buckbinder, L., and Robinson, R.P. (2002). The glucocorticoid receptor, molecular mechanism and new therapeutic opportunities. Curr. Drug Targets Inflamm. Allergy 1, 127-136.
17. Pinheiro, R.M., and Calixto, J.B. (2002). Effect of the selective CQX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. Inflamm. Res. 51, 603-610.
18. Gillitzer, R., and Goebeler, M. (2001). Chemokines in cutaneous wound healing. J. Leukoc. Biol. 69, 513-521.
19. da Silva, M.B., Farges, R.C., and Frode, T.S. (2004). Involvement of steroids in anti-inflammatory effects of PK11195 in a murine model of pleurisy. Mediators Inflamm. 13, 93-103.
20. Ren, K., Anseloni, V., Zou, S.P., et al. (2004). Characterization of basal and re-inflammation-associated long-term alteration in pain responsivity following short-lasting neonatal local inflammatory insult. Pain 110, 588-596.
21. Katori, M., Majima, M., and Harada, Y. (1998). Possible background mechanisms of the effectiveness of cyclooxygenase-2 inhibitors in the treatment of rheumatoid arthritis. Inflamm. Res. 47, Suppl 2, S107-S111.
22. Stone, P.C., Lally, F., Rahman, M., et al. (2005). Transmigrated neutrophils down-regulate the expression of VCAM-1 on endothelial cells and inhibit the adhesion of flowing lymphocytes. J. Leukoc. Biol. 77, 44-51.
23. Honmura, A., Ishii, A., Yanase, M., et al. (1993). Analgesic effect of GaAlAs diode laser irradiation on hyperalgesia in carrageenin-induced inflammation. Lasers Surg. Med. 13, 463-469.
24. Burnstein, K.L., Bellingham, D.L., Jewell, C.M., et al. (1991). Autoregulation of glucocorticoid receptor gene expression. Steroids 56, 52-58.
25. Kurihara, I., Shibata, H., Suzuki, T., et al. (2002). Expression and regulation of nuclear receptor coactivators in glucocorticoid action. Mol. Cell Endocrinol. 189, 181-189.
26. Campana, V., Moya, M., Gavotto, A., et al. (1999). The relative effects of HeNe laser and meloxicam on experimentally induced inflammation. Laser Ther. 11, 36-41.
27. Arroll, B., and Goodyear-Smith, F. (2004). Corticosteroid injections for osteoarthritis of the knee, meta-analysis. BMJ 328, 869.
28. Wood-Baker, R., Walters, E.H., and Gibson, P. (2001). Oral corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. CD001288.
29. Haker, E., and Lundeberg, T. (1991). Lateral epicondylalgia (tennis elbow): report of noneffective midlaser treatment. Arch. Phys. Med. Rehabil. 72, 984-988.
30. Krasheninnikoff, M., Ellitsgaard, N., Rogvi-Hansen, B., et al. (1994). No effect of low-power laser in lateral epicondylitis. Scand. J. Rhematol. 23, 260-263.
31. Frey, F.J., Odermatt, A., and Frey, B.M. (2004). Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension. Curr. Opin. Nephrol. Hypertens. 13, 451-458.
32. Kumar, S., Singh, R.J., Reed, A.M., et al. (2004). Cushing's syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients. Pediatrics 113, 1820-1824.
33. Scanlon, P.D., Connett, J.E., Wise, R.A., et al. (2004). Loss of bone density with inhaled triamcinolone in Lung Health Study 11. Am. J. Respir. Crit. Care Med. 170, 1302-1309.
34. Hay, E.M., Paterson, S.M., Lewis, M., et al. (1999). Pragmatic randomised controlled trial of local corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in primary care. BMJ 319, 964-968.
35. Smidt, N., van der Windt, D.A., Assendelft, W.J., et al. (2002). Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial. Lancet 359, 657-662.